谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

2014P Overall Survival (OS) Results in Phase II Trial of Cabozantinib (CABO) Plus Durvalumab (DURVA) in Patients with Urothelial Carcinoma (UC) or Non-Uc Variant Histologies (VH) after Platinum Chemotherapy (ARCADIA)

P. Giannatempo, A. Polymeropoulos,M. Stellato,P. Ambrosini,E. Gusmaroli, C. Cavalli,V. Guadalupi,M. Claps,D. Raggi,A. Rametta,C. Ortega,M. Tucci,S. Buti,S. Pipitone,R. Iacovelli,G. Calareso,A. Alessi,G. Procopio,R. Miceli,A. Necchi

Annals of Oncology（2024）

引用 0|浏览7
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要